Emerging Therapies is Fastest Growing Segment Fueling the Growth of Recombinant Human EGF Market


 The global Recombinant Human EGF Market is estimated to be valued at US$ 10,251.1 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Recombinant human epidermal growth factor (EGF) is a protein that stimulates cell growth, proliferation and differentiation by binding to its receptor. EGF is used in cell cultures to promote cell growth and differentiation. It also helps in wound healing and tissue repair processes.

Market key trends:
Recombinant human EGF has wide applications in wound healing, tissue engineering and regenerative medicines which is a major factor fueling market growth. It aids in tissue regeneration by stimulating cell growth at the wound site. The emerging field of regenerative medicines utilizes recombinant human EGF to develop novel therapies for chronic wounds, genetic disorders and for organ regeneration. For example, EGF loaded polymer scaffold are being developed to promote wound healing in chronic ulcers such as diabetic foot ulcers.
Segment Analysis

The global Recombinant Human (EGF) market is segmented based on source, application, and end-user. By source, the yeast segment dominates the market, accounting for around 40% share in 2023. Yeast is the preferred source for EGF production due to its ability to effectively express the human EGF gene and produce the growth factor in large quantities.

By application, the scientific research segment holds the largest share as EGF finds wide usage in cell culture media for promoting cell proliferation. The therapeutic applications segment is expected to witness fastest growth during the forecast period supported by ongoing clinical research evaluating EGF for wound healing and skin disorders.

Key Takeaways

The global Recombinant Human (EGF) market is expected to witness high growth, exhibiting CAGR of 9.3% over the forecast period, due to increasing demand for cell culture reagents and growth factors in research laboratories and biopharmaceutical companies.

Regional analysis - North America dominates the global market, occupying over 35% share. Higher research intensity and presence of leading market players in the US and Canada drive the regional market. Asia Pacific is poised to be the fastest growing regional market during the forecast period supported by growing R&D investments in China, India, and South Korea.

Key players - Key players operating in the Recombinant Human (EGF) market are Thermo Fisher Scientific, FUJIFILM Irvine Scientific, Inc., ScienCell Research Laboratories, R&D Systems, Abcam PLC, Cell Sciences, Inc., Eurofins DiscoverX, PeproTech, Inc., RayBiotech, Inc., Prospec-Tany TechnoGene Ltd., Miltenyi Biotec, Tonbo Biosciences, BioLegend, Inc., EnQuire BioReagents, STEMCELL Technologies Inc., Cell Guidance Systems Ltd., Creative BioMart, Sino Biological Inc., and BioVision, Inc. Thermo Fisher Scientific and FUJIFILM Irvine Scientific are the largest players based on products sales.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more